This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: H. Lundbeck A/s. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ferran Planas Padrós: Innovator in Orexin Receptor Agonists
Introduction
Ferran Planas Padrós is a notable inventor based in Valby, Denmark. He has made significant contributions to the field of pharmacology, particularly in the development of novel compounds that target specific receptors in the human body.
Latest Patents
One of his key patents is titled "Spiromacrocyclic orexin 2 receptor agonists." This invention relates to novel spiro-macrocyclic compounds of general formula (I), which function as Orexin 2 receptor agonists. This patent highlights his innovative approach to addressing various health issues through targeted receptor modulation. Ferran holds 1 patent in this area.
Career Highlights
Ferran Planas Padrós is currently employed at H. Lundbeck A/S, a leading global pharmaceutical company specializing in brain diseases. His work at Lundbeck has allowed him to focus on developing therapies that can improve the lives of patients suffering from neurological disorders.
Collaborations
Ferran collaborates with Wanwan Yu, who is also involved in research and development at H. Lundbeck A/S. Their partnership exemplifies the collaborative spirit that drives innovation in the pharmaceutical industry.
Conclusion
Ferran Planas Padrós is a dedicated inventor whose work on Orexin 2 receptor agonists represents a significant advancement in pharmacological research. His contributions continue to pave the way for new therapeutic options in treating neurological conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile